Retireful LLC Sells 612 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Retireful LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,750 shares of the medical equipment provider’s stock after selling 612 shares during the quarter. Intuitive Surgical accounts for 0.6% of Retireful LLC’s holdings, making the stock its 28th biggest holding. Retireful LLC’s holdings in Intuitive Surgical were worth $860,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Portfolio Design Labs LLC boosted its position in shares of Intuitive Surgical by 479.7% during the third quarter. Portfolio Design Labs LLC now owns 3,519 shares of the medical equipment provider’s stock valued at $1,729,000 after buying an additional 2,912 shares during the period. First Horizon Advisors Inc. grew its position in Intuitive Surgical by 5.0% in the 3rd quarter. First Horizon Advisors Inc. now owns 6,707 shares of the medical equipment provider’s stock valued at $3,295,000 after acquiring an additional 318 shares during the last quarter. Advisors Asset Management Inc. increased its stake in Intuitive Surgical by 18.9% in the third quarter. Advisors Asset Management Inc. now owns 14,240 shares of the medical equipment provider’s stock worth $6,996,000 after purchasing an additional 2,265 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Intuitive Surgical during the third quarter worth $11,356,000. Finally, NS Partners Ltd grew its holdings in shares of Intuitive Surgical by 2.3% in the third quarter. NS Partners Ltd now owns 73,518 shares of the medical equipment provider’s stock worth $36,117,000 after purchasing an additional 1,632 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This represents a 93.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 396 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $486.88, for a total transaction of $192,804.48. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,680,761.28. The trade was a 6.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 91,178 shares of company stock worth $45,897,071 in the last three months. 0.80% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research analyst reports. Royal Bank of Canada lifted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James upped their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Finally, Citigroup raised their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $524.61.

Intuitive Surgical Trading Up 1.4 %

ISRG opened at $538.82 on Wednesday. The firm has a market capitalization of $191.92 billion, a PE ratio of 86.63, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $304.50 and a twelve month high of $544.38. The firm’s 50-day moving average price is $501.42 and its 200 day moving average price is $460.69.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.